Response to "in vivo secretion of anti-CD3 × anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement".

Kota Iwahori Xiao-Tong Song Stephen Gottschalk

Mol Ther

1] Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, Texas, USA [2] Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA [3] Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA [4] Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Published: April 2015

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395792	PMC
http://dx.doi.org/10.1038/mt.2015.37	DOI Listing

Publication Analysis

Top Keywords

response "in

"in vivo

vivo secretion

secretion anti-cd3

anti-cd3 anti-tumor

anti-tumor bispecific

bispecific antibodies

antibodies gene-modified

gene-modified cells

cells decade

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!